Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Biospecimen banking: The pathway to personalized medicine for patients with cancer — Richard A Scolyer (2012) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Biospecimen banking: The pathway to personalized medicine for patients with cancer
Shared by
Richard A Scolyer
Biospecimen banking: The pathway to personalized medicine for patients with cancer
Editorial Material
2012
en
Authors
Richard A Scolyer
JT
John F. Thompson
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2013
Exploiting Tumor Vulnerabilities: Epigenetics, Cancer Metabolism and the mTOR Pathway in the Era of Personalized Medicine
Cristina Muñoz‐Pinedo
,
Eva González‐Suárez
,
Anna Portela
,
Antonio Gentilella
,
Manel Esteller
Article
2013
Epigenetic profiling joins personalized cancer medicine
Holger Heyn
,
Jesús Méndez‐González
,
Manel Esteller
Article
2020
Engineering Patient-on-a-Chip Models for Personalized Cancer Medicine
David Caballero
,
Rui L Reis
,
Subhas C. Kundu
Article
2017
Organ-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient
David Caballero
,
Sandeep Kaushik
,
Vítor M. Correlo
,
Joaquím M. Oliveira
,
Rui L Reis
,
Subhas C. Kundu
Article
2019
Organoids: Avatars for Personalized Medicine
Hans Clevers
Discussion(0)
No comments yet. Be the first to comment.